Neulasta 6mg/0.6ml (Pegfilgrastim)
What is Neulasta 6mg/0.6ml (Pegfilgrastim) ?
Neulasta 6mg/0.6ml (Pegfilgrastim) is a man-made form of a protein that stimulates the growth of white blood cells in your body. White blood cells help your body fight against infection.
Neulasta 6mg/0.6ml (Pegfilgrastim) is used to treat neutropenia (low counts of a certain type of white blood cell known as neutrophils) for people who have certain types of cancer and are receiving a type of chemotherapy that slows down white blood cell production.
Neulasta is available in a single-use syringe that contains 6 mg of pegfilgrastim.
Each 0.6 mL single-use syringe of sterile, clear, colourless, preservative-free liquid for subcutaneous administration contains 6 mg of pegfilgrastim (based on protein mass only). Nonmedicinal ingredients: polysorbate 20, sodium acetate, sorbitol, and water for injection, USP; pH: 4.0. The needle cover on the prefilled syringe contains dry natural rubber (a derivative of latex).
How to use ?
The recommended adult dose of pegfilgrastim is 6 mg given by subcutaneous (under the skin) injection after each cycle of chemotherapy. Pegfilgrastim should not be given less than 14 days before chemotherapy and not until 24 hours after chemotherapy.
Pegfilgrastim is usually given under medical supervision. If you are giving pegfilgrastim to yourself, your doctor or health care professional will instruct you on how to use pegfilgrastim properly. It is important to use this medication exactly as prescribed by your doctor.
Do not shake this medication vigorously. Shaking pegfilgrastim damages the medication, making it less effective. This medication should be stored in the refrigerator and protected from light. Freezing should be avoided, but if the medication is accidentally frozen, allow it to thaw in the refrigerator before being given. If the medication is accidentally frozen 2 times or is left at room temperature for more than 72 hours, it should be discarded.
The following side effects occur:
signs of an enlarged spleen (e.g., upper left abdominal pain or pain at the tip of the shoulder pain)
symptoms of kidney injury (e.g., puffiness in the face or ankles, blood in the urine or brown coloured urine, decreased frequency of urination)
Stop taking the medication and seek immediate medical attention if any of the following occur:
a severe allergic reaction (e.g., hives, shortness of breath, wheezing, swelling of the face or throat, fast heart rate, dizziness)
signs of acute respiratory distress syndrome (e.g., fever, shortness of breath, cough, or lung congestion)
symptoms of capillary leak syndrome (e.g., swelling or puffiness, difficulty breathing, abdominal swelling, tiredness, feeling of fullness)
Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking this medication.
There may be an interaction between pegfilgrastim and any of the following:
other cytokine medications (e.g., growth factors).
When using the On-body Injector: Avoid traveling, driving, or operating machinery while wearing the device.
Other drugs may interact with pegfilgrastim, including prescription and over-the-counter medicines, vitamins, and herbal products.